Page 6 - Ben Inker News Today

Publishing date: Dec 31, 2020  •  December 31, 2020  •  5 minute read  •  Article content LONDON — Last December, the first infection with the new coronavirus was reported to the World Health Organization. Twelve months later, as the charts below show, global financial markets have been on a roller coaster like no other. JANUARY JITTERS Try refreshing your browser, or A (markets) journal of the plague year Back to video The coronavirus wasn’t even the first thing that spooke...

A (markets) journal of the plague year Last December the first infection with the new coronavirus was reported to the World Health Organization. Twelve months later, as the charts below show, global financial markets have been on a roller coaster like no other. The virus even wasn’t the first thing that spooked the markets this year. The tone was set when an escalation of an oil market turf war between Saudi Arabia and Russia sent oil prices crashing over 5% on Jan 8. Just days later though C...

» Apple will gain another 32% on bullish outlook for the iPhone 12 and 5G technology supercycle, Wedbush says Apple will gain another 32% on bullish outlook for the iPhone 12 and 5G technology supercycle, Wedbush says Shalini NagarajanDec 15, 2020, 20:06 IST Stanislav Kogiku/SOPA Images/LightRocket via Getty Images Strong demand for the iPhone 12 will set Apples shares up for a 32% gain in 2021 as it smashes previous sales records for its mobile phones, Wedbush said on Tuesday. Wedbush expe...

GMO This story is available exclusively to Insider subscribers. Become an Insider and start reading now. Value stocks have become extremely cheap relative to growth stocks, creating a valuation disparity last seen during the tech bubble, according to Ben Inker, head of asset allocation at GMO. To profit from the growth "bubble," GMO launched a new long/short equity strategy that aims to sell overvalued stocks while loading up on ...

Nasdaq composite: 12,440.04, up 0.5% Advertisement Index futures gained early Monday as the first doses of Pfizer and BioNTechs COVID-19 vaccine were delivered in the US. Regulators on Friday approved the vaccine for emergency use, marking a major step forward in fighting the pandemic. The US Food and Drug Administration is also set to begin evaluating Modernas vaccine this week, setting the stage for an emergency use authorization before the end of the year. Yet soaring case counts across the ...

Oppenheimers John Stoltzfus. The chief investment strategist said that the successful rollout of several COVID-19 vaccines will lead to "material progress in reversing the societal and economic disruptions wrought by the pandemic since Q1 2020." Oppenheimer is overweight US equities and favors "meaningful exposure" to international developed and emerging markets. The firm is the latest on Wall Street to initiate a double-digit 2021 year-end price target for the S&P 500. . The S&P 500 could ...